Valeo Financial Advisors, LLC Alkermes Plc. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 13, 2020	SELL	$13.06 - $21.24 $261 - $424	-20 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$17.29 - $21.74 $345 - $434	20 New	20 $0
Q3 2019 Oct 15, 2019	SELL	$19.51 - $24.28 $390 - $485	-20 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$21.47 - $37.33 $429 - $746	20 New	20 $0
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $5,840 - $7,395	-144 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$53.61 - $67.26 $7,719 - $9,685	144 New	144 $8,000

363

182M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.94B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.